BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25069863)

  • 21. Brain metastasis from ovarian carcinoma: Analysis of eight cases from a single radiotherapy center.
    Bahat Z; Cakmak VA; Cakir E
    Taiwan J Obstet Gynecol; 2020 Sep; 59(5):711-717. PubMed ID: 32917323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of the epithelial cell adhesion molecule is associated with a more favorable prognosis and response to platinum-based chemotherapy in ovarian cancer.
    Woopen H; Pietzner K; Richter R; Fotopoulou C; Joens T; Braicu EI; Mellstedt H; Mahner S; Lindhofer H; Darb-Esfahani S; Denkert C; Sehouli J
    J Gynecol Oncol; 2014 Jul; 25(3):221-8. PubMed ID: 25045435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome and clinical management of 275 patients with advanced ovarian cancer International Federation of Obstetrics and Gynecology II to IV inside the European Ovarian Cancer Translational Research Consortium-OVCAD.
    Chekerov R; Braicu I; Castillo-Tong DC; Richter R; Cadron I; Mahner S; Woelber L; Marth C; Van Gorp T; Speiser P; Zeillinger R; Vergote I; Sehouli J
    Int J Gynecol Cancer; 2013 Feb; 23(2):268-75. PubMed ID: 23358178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival Impact of Optimal Surgical Cytoreduction in Recurrent Epithelial Ovarian Cancer with Brain Metastasis.
    Keskin S; Küçücük S; Ak N; Atalar B; Sarı M; Sozen H; Ibis K; Topuz S; Saip P
    Oncol Res Treat; 2019; 42(3):101-106. PubMed ID: 30661076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gamma-knife radiosurgery as an optimal treatment modality for brain metastases from epithelial ovarian cancer.
    Lee YK; Park NH; Kim JW; Song YS; Kang SB; Lee HP
    Gynecol Oncol; 2008 Mar; 108(3):505-9. PubMed ID: 18191184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: a case series.
    Fagotti A; Petrillo M; Costantini B; Fanfani F; Gallotta V; Chiantera V; Turco LC; Bottoni C; Scambia G
    Gynecol Oncol; 2014 Feb; 132(2):303-6. PubMed ID: 24378877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidrug resistance gene (MDR-1) and risk of brain metastasis in epithelial ovarian, fallopian tube, and peritoneal cancer.
    Matsuo K; Eno ML; Ahn EH; Shahzad MM; Im DD; Rosenshein NB; Sood AK
    Am J Clin Oncol; 2011 Oct; 34(5):488-93. PubMed ID: 20921883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study.
    Olawaiye AB; Java JJ; Krivak TC; Friedlander M; Mutch DG; Glaser G; Geller M; O'Malley DM; Wenham RM; Lee RB; Bodurka DC; Herzog TJ; Bookman MA
    Gynecol Oncol; 2018 Oct; 151(1):18-23. PubMed ID: 30135020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival.
    Teckie S; Makker V; Tabar V; Alektiar K; Aghajanian C; Hensley M; Beal K
    Radiat Oncol; 2013 Feb; 8():36. PubMed ID: 23414446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with primary or secondary cytoreductive surgery in the treatment of advanced epithelial ovarian cancer.
    Manzanedo I; Pereira F; Pérez-Viejo E; Serrano Á; Hernández-García M; Martínez-Torres B; Rihuete-Caro C; Calzas J; Cueto M
    Minerva Ginecol; 2017 Apr; 69(2):119-127. PubMed ID: 27415829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral metastases from epithelial ovarian carcinoma treated with carboplatin.
    Cooper KG; Kitchener HC; Parkin DE
    Gynecol Oncol; 1994 Nov; 55(2):318-23. PubMed ID: 7959302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant melanoma brain metastases: Treatment results and prognostic factors--a single-center retrospective study.
    Ostheimer C; Bormann C; Fiedler E; Marsch W; Vordermark D
    Int J Oncol; 2015; 46(6):2439-48. PubMed ID: 25891163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Practice of Adjuvant Chemotherapy in Patients with Early-Stage Epithelial Ovarian Cancer.
    Frielink LM; Pijlman BM; Ezendam NP; Pijnenborg JM
    Chemotherapy; 2016; 61(6):287-94. PubMed ID: 27074010
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    González García B; García Vicente AM; Jiménez Londoño GA; Pena Pardo FJ; Bellón Guardia ME; Talavera Rubio MP; Palomar Muñoz A; Gómez Herrero P; Soriano Castrejón ÁM
    Rev Esp Med Nucl Imagen Mol; 2017; 36(4):233-240. PubMed ID: 28284928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative metabolic parameters measured on F-18 FDG PET/CT predict survival after relapse in patients with relapsed epithelial ovarian cancer.
    Kim CY; Jeong SY; Chong GO; Son SH; Jung JH; Kim DH; Lee SW; Ahn BC; Lee J
    Gynecol Oncol; 2015 Mar; 136(3):498-504. PubMed ID: 25557270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One year maintenance of carboplatin in patients with epithelial ovarian cancer--a phase II study.
    Safra T; Kovner F; Barak N; Inbar MJ; Ron IG
    Isr Med Assoc J; 2006 Jan; 8(1):27-9. PubMed ID: 16450747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A patient with brain metastasis from ovarian cancer who showed complete remission after multidisciplinary treatment.
    Suzuki M; Tsukagoshi S; Ohwada M; Koumura Y; Sato I
    Gynecol Oncol; 1999 Sep; 74(3):483-6. PubMed ID: 10479515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary debulking surgery vs. neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer.
    Bian C; Yao K; Li L; Yi T; Zhao X
    Arch Gynecol Obstet; 2016 Jan; 293(1):163-168. PubMed ID: 26198168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous/intraperitoneal paclitaxel and intraperitoneal carboplatin in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma: a feasibility study.
    Nagao S; Iwasa N; Kurosaki A; Nishikawa T; Ohishi R; Hasegawa K; Goto T; Fujiwara K
    Int J Gynecol Cancer; 2012 Jan; 22(1):70-5. PubMed ID: 22146766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of brain metastases from ovarian cancer using gamma-knife radiosurgery.
    Kawana K; Yoshikawa H; Yokota H; Onda T; Nakagawa K; Tsutsumi O; Taketani Y
    Gynecol Oncol; 1997 May; 65(2):357-9. PubMed ID: 9159351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.